Agilent Files for $750M Notes Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies has filed a prospectus with the US Securities and Exchange Commission to offer $750 million in senior notes.

The firm said that of these notes, $500 million will mature in September 2015 and will bear an annual interest rate of 5.5 percent, while $250 million will mature in September 2012 with an annual interest rate of 4.45 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.